In melanoma A375 cells, treatment with BBR was also found to decrease the metastatic potential of cancer cells due to AMPK activation and inhibition of the ERK-signaling pathway, while the levels of COX-2 proteins were also reduced [114] (Table 2). This evidence concerns the gene PTGS2 and melanoma.